Selected research
Market Structure
Global Gliquidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gliquidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gliquidone include Boehringer Ingelheim, Dexa Medica, Menarini Belgium, CR Double-Crane, Jinheng Pharma, Vanguard Pharma, Yiling Pharma and TIPR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gliquidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gliquidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gliquidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gliquidone market size, projected growth trends, production technologies, key applications, and end-use industries.
Gliquidone Segment by Company
Boehringer Ingelheim
Dexa Medica
Menarini Belgium
CR Double-Crane
Jinheng Pharma
Vanguard Pharma
Yiling Pharma
TIPR
Gliquidone Segment by Type
Glequinone Tablets
Glequinone Capsule
Glequinone Sustained Release Tablets
Others
Gliquidone Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Gliquidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gliquidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gliquidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gliquidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gliquidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gliquidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Glequinone Tablets
- Glequinone Capsule
- Glequinone Sustained Release Tablets
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Boehringer Ingelheim
- Dexa Medica
- Menarini Belgium
- CR Double-Crane
- Jinheng Pharma
- Vanguard Pharma
- Yiling Pharma
- TIPR
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gliquidone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gliquidone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gliquidone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gliquidone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gliquidone Market Dynamics
- 2.1 Gliquidone Industry Trends
- 2.2 Gliquidone Industry Drivers
- 2.3 Gliquidone Industry Opportunities and Challenges
- 2.4 Gliquidone Industry Restraints
3 Gliquidone Market by Manufacturers
- 3.1 Global Gliquidone Revenue by Manufacturers (2021-2026)
- 3.2 Global Gliquidone Sales by Manufacturers (2021-2026)
- 3.3 Global Gliquidone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gliquidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gliquidone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gliquidone Manufacturers, Product Type & Application
- 3.7 Global Gliquidone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gliquidone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gliquidone Players Market Share by Revenue in 2025
- 3.8.3 2025 Gliquidone Tier 1, Tier 2, and Tier 3
4 Gliquidone Market by Type
- 4.1 Gliquidone Type Introduction
- 4.1.1 Glequinone Tablets
- 4.1.2 Glequinone Capsule
- 4.1.3 Glequinone Sustained Release Tablets
- 4.1.4 Others
- 4.2 Global Gliquidone Sales by Type
- 4.2.1 Global Gliquidone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gliquidone Sales by Type (2021-2032)
- 4.2.3 Global Gliquidone Sales Market Share by Type (2021-2032)
- 4.3 Global Gliquidone Revenue by Type
- 4.3.1 Global Gliquidone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gliquidone Revenue by Type (2021-2032)
- 4.3.3 Global Gliquidone Revenue Market Share by Type (2021-2032)
5 Gliquidone Market by Application
- 5.1 Gliquidone Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Gliquidone Sales by Application
- 5.2.1 Global Gliquidone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gliquidone Sales by Application (2021-2032)
- 5.2.3 Global Gliquidone Sales Market Share by Application (2021-2032)
- 5.3 Global Gliquidone Revenue by Application
- 5.3.1 Global Gliquidone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gliquidone Revenue by Application (2021-2032)
- 5.3.3 Global Gliquidone Revenue Market Share by Application (2021-2032)
6 Global Gliquidone Sales by Region
- 6.1 Global Gliquidone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gliquidone Sales by Region (2021-2032)
- 6.2.1 Global Gliquidone Sales by Region (2021-2026)
- 6.2.2 Global Gliquidone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gliquidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gliquidone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gliquidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gliquidone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gliquidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gliquidone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gliquidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gliquidone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gliquidone Revenue by Region
- 7.1 Global Gliquidone Revenue by Region
- 7.1.1 Global Gliquidone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gliquidone Revenue by Region (2021-2026)
- 7.1.3 Global Gliquidone Revenue by Region (2027-2032)
- 7.1.4 Global Gliquidone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gliquidone Revenue (2021-2032)
- 7.2.2 North America Gliquidone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gliquidone Revenue (2021-2032)
- 7.3.2 Europe Gliquidone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gliquidone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gliquidone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gliquidone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gliquidone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Company Information
- 8.1.2 Boehringer Ingelheim Business Overview
- 8.1.3 Boehringer Ingelheim Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Boehringer Ingelheim Gliquidone Product Portfolio
- 8.1.5 Boehringer Ingelheim Recent Developments
- 8.2 Dexa Medica
- 8.2.1 Dexa Medica Company Information
- 8.2.2 Dexa Medica Business Overview
- 8.2.3 Dexa Medica Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Dexa Medica Gliquidone Product Portfolio
- 8.2.5 Dexa Medica Recent Developments
- 8.3 Menarini Belgium
- 8.3.1 Menarini Belgium Company Information
- 8.3.2 Menarini Belgium Business Overview
- 8.3.3 Menarini Belgium Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Menarini Belgium Gliquidone Product Portfolio
- 8.3.5 Menarini Belgium Recent Developments
- 8.4 CR Double-Crane
- 8.4.1 CR Double-Crane Company Information
- 8.4.2 CR Double-Crane Business Overview
- 8.4.3 CR Double-Crane Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CR Double-Crane Gliquidone Product Portfolio
- 8.4.5 CR Double-Crane Recent Developments
- 8.5 Jinheng Pharma
- 8.5.1 Jinheng Pharma Company Information
- 8.5.2 Jinheng Pharma Business Overview
- 8.5.3 Jinheng Pharma Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jinheng Pharma Gliquidone Product Portfolio
- 8.5.5 Jinheng Pharma Recent Developments
- 8.6 Vanguard Pharma
- 8.6.1 Vanguard Pharma Company Information
- 8.6.2 Vanguard Pharma Business Overview
- 8.6.3 Vanguard Pharma Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vanguard Pharma Gliquidone Product Portfolio
- 8.6.5 Vanguard Pharma Recent Developments
- 8.7 Yiling Pharma
- 8.7.1 Yiling Pharma Company Information
- 8.7.2 Yiling Pharma Business Overview
- 8.7.3 Yiling Pharma Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Yiling Pharma Gliquidone Product Portfolio
- 8.7.5 Yiling Pharma Recent Developments
- 8.8 TIPR
- 8.8.1 TIPR Company Information
- 8.8.2 TIPR Business Overview
- 8.8.3 TIPR Gliquidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 TIPR Gliquidone Product Portfolio
- 8.8.5 TIPR Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gliquidone Value Chain Analysis
- 9.1.1 Gliquidone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gliquidone Production Mode & Process
- 9.2 Gliquidone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gliquidone Distributors
- 9.2.3 Gliquidone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst